YD0293

· Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YD0293, covering 2025-08-17 to 2025-08-17. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of YD0293 in Healthy Subjects [Phase 1]